Involvement of AP-2 binding sites in regulation of human beta-glucuronidase

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 370, Issue 5, 2004, Pages 331-339

  Kunert Keil, Christiane ^a   Sperker, Bernhard ^a   Bien, Sandra ^a   Wolf, Gabriele ^a   Grube, Markus ^a   Kroemer, Heyo K ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Calcium ionophore A23187; HepG2; Human glucuronidase; Regulation; Transcription factor AP 2

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIMYCIN; PRODRUG; THAPSIGARGIN; TRANSCRIPTION FACTOR AP 2;

5' UNTRANSLATED REGION; ARTICLE; BETA GLUCURONIDASE GENE; BINDING SITE; CELL STRAIN HEPG2; CIS ISOMER; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME INHIBITION; FRAGMENTATION REACTION; GEL MOBILITY SHIFT ASSAY; GENE; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSFECTION; HEPATOMA CELL; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR CLONING; PROMOTER REGION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION;

BINDING SITES; CELL LINE, TUMOR; DNA-BINDING PROTEINS; GLUCURONIDASE; HUMANS; PROTEIN BINDING; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS;

EID: 11144324903     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-004-0989-3     Document Type: Article

References (37)

1. Akiyama Y (1995) TFSEARCH: searching transcription factor binding sites. http://www.rwcp.or.jp/papia/
2. Albin N, Massaad L, Toussaint C, Mathieu MC, Morizet J, Parise O, Gouyette A, Chabot GG (1993) Main drug-metabolizing enzyme systems in human breast tumours and peritumoral tissues. Cancer Res 53:3541-3546
3. Bar-Eli M (2001) Gene regulation in melanoma progression by the AP-2 transcription factor. Pigment Cell Res 14:78-85
4. Bosher JM, Totty NF, Hsuan JJ, Williams T, Hurst HC (1996) A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene 13:1701-1707
5. Bosslet K, Czech J, Hoffmann D (1994) Tumor-selective prodrug activation by fusion protein-mediated catalysis. Cancer Res 54:2151-2159
6. Bosslet K, Czech J, Hoffmann D (1995) A novel one-step tumor-selective prodrug activation system. Tumor Target 1:45-50
7. Bosslet K, Straub R, Blumrich M, Czech J, Gerken M, Sperker B, Kroemer HK, Gesson JP, Koch M, Monneret C (1998) Elucidation of the mechanism enabling tumor selective prodrug monotherapy. Cancer Res 58:1195-1201
8. Chazaud C, Oulad-Abdelghani M, Bouillet P, Decimo D, Chambon P, Dolle P (1996) AP-2.2, a novel gene related to AP-2, is expressed in the forebrain, limbs and face during mouse embryo-genesis. Mech Dev 54:83-94
9. Damberg M, Ekblom J, Oreland L (2000) Chronic pharmacological treatment with certain antidepressants alters the expression and DNA-binding activity of transcription factor AP-2. Life Sci 68:669-678
10. Fishman WH, Kalo K, Anstiss CL, Green S (1967) Human serum β-glucuronidase; its measurement and some of its properties. Clin Chim Acta 15:435-447
11. Gaynor RB, Muchardt C, Xia Y, Klisak I, Mohandas T, Sparkes RS, Lusis AJ (1991) Localization of the gene for the DNA-binding protein AP-2 to human chromosome 6p22.3-pter. Genomics 10:1100-1102
12. Gehrmann MC, Opper M, Sedlacek HH, Bosslet K, Czech J (1994) Biochemical properties of recombinant human β-glucuronidase synthesized in baby hamster kidney cells. Biochem J 301:821-828
13. Grube M, Kunert-Keil C, Sperker B, Kroemer HK (2003) Verapamil regulates activity and mRNA-expression of human β-glucuronidase in HepG2 cells. Naunyn-Schmiedebergs Arch Pharmacol 368:463-469
14. Hayashi T, Usui M, Nishioka J, Zhang ZX, Suzuki K (1998) Regulation of the human protein C inhibitor gene expression in HepG2 cells: role of Sp1 and AP2. Biochem J 332:573-582
15. Hilger-Eversheim K, Moser M, Schorle H, Buettner R (2000) Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene 260:1-12
16. Islam MR, Waheed A, Shah GN, Tomatsu S, Sly WS (1999) Human egasyn binds β-glucuronidase but neither the esterase active site of egasyn nor the C terminus of β-glucuronidase is involved in their interaction. Arch Biochem Biophys 372:53-61
17. Jain S, Drendel WB, Chen ZW, Mathews FS, Sly WS, Grubb JH (1996) Structure of human β-glucuronidase reveals candidate lysosomal targeting and active-site motifs. Nat Struct Biol 3:375-381
18. Kim HS, Hong SJ, LeDoux MS, Kim KS (2001) Regulation of the tyrosine hydroxylase and dopamine β-hydroxylase genes by the transcription factor AP-2. J Neurochem 76:280-294
19. Lüscher B, Mitchell PJ, Williams T, Tjian R (1989) Regulation of transcription factor AP-2 by the morphogen retinoic acid and by second messengers. Genes Dev 3:1507-1517
20. Miller RD, Hoffmann JW, Powell PP, Kyle JW, Shipley JM, Bachinsky DR, Sly WS (1990) Cloning and characterization of the human beta-glucuronidase gene. Genomics 7:280-283
21. Mitchell PJ, Timmons PM, Hebert JM, Rigby PW, Tjian R (1991) Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev 5:105-119
22. Moser M, Imhof A, Pscherer A, Bauer R, Amselgruber W, Sinowatz F, Hofstadter F, Schule R, Buettner R (1995) Cloning and characterization of a second AP-2 transcription factor: AP-2β. Development 121:2779-2788
23. Mürdter TE, Sperker B, Kivisto KT, McClellan M, Fritz P, Friedel G, Linder A, Bosslet K, Toomes H, Dierkesmann R, Kroemer HK (1997) Enhanced uptake of doxorubicin into bronchial carcinoma: β-glucuronidase mediates release of doxorubicin from a glucuronide prodrug (HMR 1826) at the tumor site. Cancer Res 57:2440-2445
24. Mürdter TE, Friedel G, Backman JT, McClellan M, Schick M, Gerken M, Bosslet K, Fritz P, Toomes H, Kroemer HK (2002) Dose optimization of a doxorubicin prodrug (HMR 1826) in isolated perfused human lungs: low tumor pH promotes prodrug activation by beta-glucuronidase. J Pharmacol Exp Ther 301:223-228
25. Oshima A, Kyle JW, Miller RD, Hoffmann JW, Powell PP, Grubb JH, Sly WS, Tropak M, Guise KS, Gravel RA (1987) Cloning, sequencing, and expression of cDNA for human β-glucuronidase. Proc Natl Acad Sci USA 84:685-689
26. Paigen K (1989) Mammalian β-glucuronidase: genetics, molecular biology, and cell biology. Prog Nucleic Acid Res Mol Biol 37:155-205
27. Schreiber E, Matthias P, Müller MM, Schaffner W (1989) Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucleic Acids Res 17:6419
28. Shipley JM, Miller RD, Wu BM, Grubb JH, Christensen SG, Kyle JW, Sly WS (1991) Analysis of the 5′ flanking region of the human β-glucuronidase gene. Genomics 10:1009-1018
29. Sly WS, Quinton BA, McAlister WH, Rimoin DL (1973) β-Glucuronidase deficiency: report of clinical, radiologic and biochemical features of a new mucopolysaccharidosis. J Pediatr 82:249-257
30. Sperker B, Backman JT, Kroemer HK (1997a) The role of β-glucuronidase in drug disposition and drug targeting in humans. Clin Pharmacokinet 33:18-31
31. Sperker B, Mürdter TE, Schick M, Eckhardt K, Bosslet K, Kroemer HK (1997b) Interindividual variability in expression and activity of human β-glucuronidase in liver and kidney: consequences for drug metabolism. J Pharmacol Exp Ther 281:914-920
32. Sperker B, Werner U, Mürdter TE, Tekkaya C, Fritz P, Wacke R, Adam U, Gerken M, Drewelow B, Kroemer HK (2000) Expression and function of β-glucuronidase in pancreatic cancer: potential role in drug targeting. Naunyn-Schmiedebergs Arch Pharmacol 362:110-115
33. Sperker B, Tomkiewicz C, Burk O, Barouki R, Kroemer HK (2001) Regulation of human β-glucuronidase by A23187 and thapsigargin in the hepatoma cell line HepG2. Mol Pharmacol 59:177-182
34. Uchida C, Oda T, Sugiyama T, Otani S, Kitagawa M, Ichiyama A (2002) The role of Sp1 and AP-2 in basal and protein kinase A-induced expression of mitochondrial serine: pyruvate aminotransferase in hepatocytes. J Biol Chem 277:39082-39092
35. Wang CY, Lei HJ, Huang CY, Zhang Z, Mukherjee AB, Yuan CJ (2002) Induction of cyclooxygenase-2 by staurosporine through the activation of nuclear factor for IL-6 (NF-IL6) and activator protein 2 (AP2) in an osteoblast-like cell line. Biochem Pharmacol 64:177-184
36. Xu Y, Porntadavity S, St Clair DK (2002) Transcriptional regulation of the human manganese superoxide dismutase gene: the role of specificity protein 1 (Sp1) and activating protein-2 (AP-2). Biochem J 362:401-412
37. Zeng YX, Somasundaram K, el-Deiry WS (1997) AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression. Nat Genet 15:78-82